RxDoctor Payments DataLook up a doctor →

Cabometyx: payments to doctors

Payments that named Cabometyx as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$16.6M
Providers
10,466
Transactions
52,902
Average per transaction
$314

The per-transaction average — $314 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,466 providers the average total is $1,587, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Exelixis Inc.$16,558,71499.7%
Ipsen Pharma SAS$26,5500.2%
Ipsen Innovation$22,8400.1%
Ipsen Biopharmaceuticals, Inc$1,7640.0%
← All drugs & devices